Number of the records: 1  

sunitinib

  1. Subject h.sunitinib
    Subject h.Sunitinib
    Entry termssunitinib malát
    Sutent
    Scope note in EnglishAn indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.
    Pharmacology effect antineoplastiká
    inhibítory angiogenézy
    inhibítory proteínkináz
    Pharmacology effect Antineoplastic Agents
    Angiogenesis Inhibitors
    Protein Kinase Inhibitors
    Links (8) - ARTICLES
    (1) - CiBaMed
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all